The stage of clinical trials of the vaccine “Vector” directed against the coronavirus has been officially completed in Russia. The corresponding statement was made by Anna Popova, who heads the national Rospotrebnadzor.
Image via: pexeles.com
The words of the representative of the department sounded on September 30. She explained during a commentary for RIA Novosti that the testing process for “Vector” ended “literally today”, while Popova did not disclose the details.
Earlier, information appeared that more than 8 thousand cases of infection of citizens with coronavirus were recorded in Russia. Such a significant number of new diagnoses were recorded for the first time in the last three months, when the number of cases was declining.